Overall, the above studies point to the significantly increased levels of NO and products of its redox reactions in the mitochondria in the ASD animal models and autistic patients
Intracellular signaling of the aging suppressor protein Klotho
L.KamadaN
The lack of modern effective pharmacological therapy of AITD prompted us to consider the mechanisms of influence, possibilities of immunocorrection of pathogenetic factors using TG, micro/macronutrients
Genet Med (2008) 10:412.10.1097/GIM.0b013e31815efdd7 11 NealeBMKouYLiuLMaayanASamochaKESaboAet alPatterns and rates of exonic de novo mutations in autism spectrum disorders
Potential Causes of Allodynia Allodynia is associated with several neurological and metabolic conditions, including: Peripheral Neuropathy (due to diabetes, chemotherapy, or autoimmune disorders) Fibromyalgia (central pain sensitisation disorder) Migraine Disorders (involving trigeminal nerve hypersensitivity) Neuroinflammation and Immune Dysregulation (as seen in post-viral syndromes) Medication Side Effects, including possible links to GLP-1 receptor agonists Mechanisms: How GLP-1 Medications May Contribute to Allodynia GLP-1 receptor agonists (e.g., Mounjaro, Wegovy) are widely used for weight loss and glycemic control due to their role in glucose-dependent insulin secretion and appetite suppression
